GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » E10

Kangmei Pharmaceutical Co (SHSE:600518) E10 : ¥-0.48 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kangmei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥-0.48 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Kangmei Pharmaceutical Co was 30.70% per year. The lowest was -8.50% per year. And the median was 24.10% per year.

As of today (2024-06-06), Kangmei Pharmaceutical Co's current stock price is ¥1.86. Kangmei Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥-0.48. Kangmei Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Kangmei Pharmaceutical Co was 104.13. The lowest was 6.95. And the median was 49.39.


Kangmei Pharmaceutical Co E10 Historical Data

The historical data trend for Kangmei Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co E10 Chart

Kangmei Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 -0.36 -0.35 -0.41 -0.46

Kangmei Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.43 -0.44 -0.45 -0.46 -0.48

Competitive Comparison of Kangmei Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Kangmei Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangmei Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kangmei Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kangmei Pharmaceutical Co's Shiller PE Ratio falls into.



Kangmei Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kangmei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.001/115.2271*115.2271
=0.001

Current CPI (Mar. 2024) = 115.2271.

Kangmei Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201406 0.099 98.200 0.116
201409 0.108 98.900 0.126
201412 0.179 99.000 0.208
201503 0.186 99.900 0.215
201506 0.140 99.500 0.162
201509 0.153 100.500 0.175
201512 0.144 100.600 0.165
201603 0.225 102.200 0.254
201606 0.176 101.400 0.200
201609 0.164 102.400 0.185
201612 0.101 102.600 0.113
201703 0.216 103.200 0.241
201706 0.219 103.100 0.245
201709 0.200 104.100 0.221
201712 -0.249 104.500 -0.275
201803 0.051 105.300 0.056
201806 0.047 104.900 0.052
201809 0.041 106.600 0.044
201812 -0.063 106.500 -0.068
201903 0.013 107.700 0.014
201906 0.004 107.700 0.004
201909 -0.010 109.800 -0.010
201912 -0.997 111.200 -1.033
202003 -0.060 112.300 -0.062
202006 -0.229 110.400 -0.239
202009 -0.192 111.700 -0.198
202012 -5.773 111.500 -5.966
202103 -0.121 112.662 -0.124
202106 -0.067 111.769 -0.069
202109 -0.007 112.215 -0.007
202112 0.644 113.108 0.656
202203 -0.008 114.335 -0.008
202206 -0.006 114.558 -0.006
202209 -0.050 115.339 -0.050
202212 -0.126 115.116 -0.126
202303 -0.004 115.116 -0.004
202306 -0.005 114.558 -0.005
202309 -0.002 115.339 -0.002
202312 0.018 114.781 0.018
202403 0.001 115.227 0.001

Add all the adjusted EPS together and divide 10 will get our e10.


Kangmei Pharmaceutical Co  (SHSE:600518) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Kangmei Pharmaceutical Co was 104.13. The lowest was 6.95. And the median was 49.39.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Kangmei Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.
Executives
Xu Dong Jin Director
Li Jian Hua senior management
Qiu Xi Wei Director
Wang Min senior management
Peng Qin senior management
Ma Xing Tian Director
Lin Guo Xiong senior management
Zhuang Yi Qing senior management
Wen Shao Sheng Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines